COMPANY

ID4Pharma

HQ: Bridgeville, PA source · id4pharma.com ↗ · Mid-Atlantic

ID4Pharma is a biotech startup built on University of Pittsburgh technology, developing Sequesta, an SQSTM1-targeted drug for multiple myeloma; it has completed IND-enabling preclinical studies and says it is now in human clinical trials. From company website Source · Oct 12, 2026

Keywords: oncology multiple myeloma clinical-stage

Location: Bridgeville, PA · source · Oct 15, 2026

Profile checked Oct 10, 2026

4NIH grants

NIH awards 4

Annual award amounts. Total $2.3M.

Aug 30, 2019 NIH award 5R44CA210882-03 FY2019: $1,000,000 awarded for that fiscal year; activity R44 (SBIR); PI LEE, JAMES; recipient as written: ID4PHARMA, LLC, Bridgeville, PA. SQSTM1/p62-targeted Small Molecules for Multiple M source ↗
Aug 16, 2018 NIH award 4R44CA210882-02 FY2018: $1,000,000 awarded for that fiscal year; activity R44 (SBIR); PI LEE, JAMES; recipient as written: ID4PHARMA, LLC, Bridgeville, PA. SQSTM1/p62-targeted Small Molecules for Multiple M source ↗
Aug 1, 2018 NIH award 3R44CA210882-01A1S1 FY2018: $6,840 awarded for that fiscal year; activity R44 (SBIR); PI LEE, JAMES; recipient as written: ID4PHARMA, LLC, Bridgeville, PA. SQSTM1/p62-targeted Small Molecules for Multiple M source ↗
May 23, 2017 NIH award 1R44CA210882-01A1 FY2017: $300,000 awarded for that fiscal year; activity R44 (SBIR); PI LEE, JAMES; recipient as written: ID4PHARMA, LLC, Bridgeville, PA. SQSTM1/p62-targeted Small Molecules for Multiple M source ↗